Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
When to contact your healthcare provider: Severe or persistent nausea and vomiting that prevents adequate oral intake Signs of dehydration (decreased urination, dizziness, dry mouth) Severe abdominal pain, especially if persistent or radiating to the back Symptoms of hypoglycemia if taking tirzepatide with insulin or sulfonylureas (shakiness, sweating, confusion, rapid heartbeat) Unusual injection site reactions (severe pain, swelling, redness) Intractable vomiting or inability to keep fluids down Any other concerning symptoms For future injections: Review proper injection technique with your healthcare provider or a diabetes educator before your next dose
This prevents beta-3 receptor desensitization while maintaining the appetite suppression and metabolic benefits of tirzepatide
The two-year-old startup has now raised more than $4 million in venture funding
Attina G, Mastrangelo S, Ruggiero A
This is a first order rate constant and is exactly related to the corresponding half-life for the absorption process
US$ 25.75
US$ 25.85
US$ 20.70
US$ 27.71
US$ 27.55
US$ 29.44
US$ 26.37
US$ 20.86
